|
Symbol
|
RMA3QV | LZQRCH | QXPRCH | RMAKZV | AEFRTQ | RMA0TV | ADIESQ | RMBXZV | ROMRCH | AFNHTQ | RMB4JV | RMADEV | AFWPTQ | RMB5TV | MBWRCH | RMBTQV | RMB57V | Z0CI9Z | MCGRCH | ADVZSQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Multi Vonti | Multi Vonti | ZKB Reverse Convertible on worst of Last Look | Worst of Callable Reverse Convertible | Multi Reverse Convertible |
|
Sous-jacent
|
Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Givaudan / Novartis AG / Sandoz Group AG | Alcon / Lonza Group N / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | DKSH Hldg. AG / Sandoz Group AG / Siegfried Hldg. AG | Alcon / Sandoz Group AG / UBS Group AG | Galderma Group AG / Lonza Group N / Roche PS / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Sandoz Group AG | Givaudan / Novartis AG / Sandoz Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Partners Group Hldg. AG / Sandoz Group AG | ABB / Sandoz Group AG / Swisscom N | Givaudan / Novartis AG / Sandoz Group AG | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Nestlé S.A. / Roche PS / Sandoz Group AG | Nestlé S.A. / Partners Group Hldg. AG / Sandoz Group AG / VAT Group | Compagnie Financière Richemont SA / Givaudan / Sandoz Group AG / Swiss Prime Site AG | Bachem Hldg. AG / Sandoz Group AG / Zurich Insurance Group AG | ABB / Helvetia Baloise Holding AG / Sandoz Group AG | Accelleron Industries AG / Julius Baer Group / Sandoz Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
09.11.2026 | 07.08.2029 | 25.08.2027 | 01.09.2028 | 24.09.2027 | 19.11.2026 | 24.11.2027 | 20.12.2027 | 23.07.2027 | 09.02.2029 | 14.02.2028 | 01.12.2026 | 18.03.2030 | 20.03.2028 | 27.09.2028 | 26.04.2027 | 26.04.2027 | 18.05.2027 | 08.06.2028 | 19.06.2028 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
56,14 | 2 627,25 | 52,905 | 65,00 | 63,504 | 57,20 | 50,768 | 61,93 | 419,40 | 80,752 | 677,60 | 62,96 | 90,585 | 84,95 | 64,481 | 664,40 | 95,80 | 73,2825 | 62,355 | 52,115 |
| rendement max. p.a. | -1,87% | 4,10% | 7,51% | 7,29% | 6,10% | -0,78% | 9,12% | 4,78% | 5,02% | 4,72% | 14,65% | 22,91% | 5,00% | 5,83% | 4,26% | 19,94% | 2,55% | 16,25% | 9,85% | 11,07% |
| Demande | - | 100,07 | 98,54 | 94,00 | 100,29 | 99,40 | 100,32 | 99,40 | 100,01 | 99,78 | 91,70 | 98,50 | 102,26 | 101,20 | 104,97 | 94,10 | 101,10 | - | 96,87 | 97,19 |
| Offre | - | 100,92 | 99,39 | 95,20 | 101,15 | 100,60 | 101,18 | 100,40 | 100,86 | 100,63 | 92,70 | 99,50 | 103,26 | 102,20 | 105,87 | 95,10 | 102,30 | - | 97,72 | 98,04 |